XBI ETF (State Street SPDR S&P Biotech ETF) is managed by State Street Investment Management with $9.05B in net assets. XBI expense ratio is 0.35%, holding 157 positions across sectors including Health Care, Unknown, Other. Inception date: 2006-01-31.

XBI performance shows a YTD return of 15.80%. The 1-year return is 73.31% and the 5-year return is 1.45%. XBI dividend yield stands at 0.32%, paid quarterly.

XBI top holdings include Apellis Pharmaceuticals Inc (1.8%), Alkermes Plc (1.4%), Madrigal Pharmaceuticals Inc (1.4%), Tg Therapeutics Inc Common Stock (1.4%), Insmed Inc (1.3%). View all XBI holdings, sector breakdown, or dividend history.

XBI can be compared against other funds using the overlap calculator or side-by-side comparison tool. XBI alternatives are available via the screener, along with tax-loss harvesting opportunities.